MedTrace Logo

Citrate Pharmacokinetics and Regional Citrate Anticoagulation in CRRT

NCT00948558 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2009-08-06

No results posted yet for this study

Summary

1. To compare the differences of citrate pharmacokinetics in healthy individuals and critically ill patients as well as the influential factors.
2. To validate a pharmacokinetic model which has been established in a formal paper.
3. To create a safe and effective RCA-CRRT protocol.

Conditions

  • Acute Kidney Failure With or Without:
  • MODS
  • Sepsis
  • Hepatic Insufficiency

Sponsors & Collaborators

  • Shanghai Scientific and technology committe

    collaborator UNKNOWN

  • Huashan Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-03-31
Primary Completion
2010-12-31
Completion
2011-09-30

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00948558 on ClinicalTrials.gov